Clinical endpoint prediction from molecular feature sets
Leveraging Nucleic Acid-Based Circulating Analytes for Health
Learn More
Leveraging Nucleic Acid-Based Circulating Analytes for Health
Learn More
Identifying novel nucleic acid biomarkers in plasma for diagnostics.
Creating accurate, non-invasive tests for clinical use.
Applying our tests to cancer care.
hsa-miR-96, hsa-miR-183, hsa-miR-182, and hsa-miR-93 as pan-adenocarcinoma miRNA markers,..
Read More
Establishment of three independent panels of microRNAs..
Read More
This study explores a novel, noninvasive method for characterizing Alzheimer's disease (AD) through the analysis of circulating, cell-free messenger RNA (cf-mRNA) found in blood plasma...
Read More
A groundbreaking 2021 study on cell-free RNA (cfRNA) as a novel biomarker for cancer detection...
Read More
A landmark 1999 study by Kopreski et al. published in Clinical Cancer Research demonstrated the detection of tumor messenger RNA...
Read More
